Mouillot T, Filancia A, Boirie Y, Brindisi MC, Hafnaoui N, Van Wymelbeke V, et al
Es decir, su uso no tiene fines estticos, sino mejorar la salud
The gastrointestinal effects, including nausea, vomiting, diarrhea, and constipation , affect roughly 40-50% of users at therapeutic doses
Some users combine it with GLP-1 agonists for additional glycemic control
The idea is that microdosing can: Reduce side effects Its common to experience side effects when taking GLP-1s, especially gastrointestinal issues including: Nausea Vomiting Diarrhea The smaller the dose, the lower the odds of side effects, so microdosing can help someone feel good enough to stay on the medication
The future of GLP-1 therapy lies in this thoughtful integration of precise dosing strategies with comprehensive wellness approaches, always under careful medical guidance